José Trevejo, MD, PhD, has been named Chief Medical Officer of Tarsus Pharmaceuticals. Dr. Trevejo has more than 20 years of experience in clinical development of novel treatments for serious diseases.
Eyenovia has made changes to its Board of Directors.
Santen, in partnership with UCL Institute of Ophthalmology (IoO), has announced the launch of the company’s first external research laboratory in Europe.
Tarsus Pharmaceuticals announced that Elizabeth Yeu, MD, has been appointed to its Board of Directors. Dr. Yeu will continue to serve as the company’s Chief Medical Advisor.
RxSight welcomes Tamara R. Fountain, MD, and Shweta Singh Maniar into its Board of Directors.
Euclid Vision has announced the official rollout of MyEuclid, an interactive, web-based customer portal designed to drive practice efficiency and optimize Euclid Ortho-K fits.
TissueTech has appointed Ted Davis as the company’s new president and CEO. Mr. Davis, a seasoned biologics and orthopedics executive, succeeds TissueTech founder and former CEO Amy Tseng, who retired on January 3.